Why Concentration Plans Drift During Lab-to-Lab Transfer
A protocol transfer between laboratories is not simply a file handover. An in vitro method carries assumptions about diluents, vessel geometry, assay volume, plate format, incubation conditions and the batch identity of each material. The concentration plan is the part most likely to be copied into a new document without those assumptions. In the sending lab it may be an informal note such as “1 mg/mL working solution”; in the receiving lab it can be read as a final assay concentration, a stock concentration or something closer to a dosing instruction. That drift is dangerous because a laboratory concentration plan is a record of an in vitro preparation, not a dose, injection schedule or administration instruction.
The most common triggers are familiar: mixed units such as mg/mL, µg/mL and µM; missing diluent identity; an unstated vehicle; a “working solution” line with no dilution series; and conversions made without the molecular weight from the relevant batch CoA. A document may also inherit a template that was never intended for research materials, so a field labelled “dose” invites the wrong interpretation. The receiving lab then spends time reconstructing context instead of checking the science. The correction is not more shorthand; it is a clearer boundary between material identity, stock preparation for the assay, and the final concentration in the in vitro system. Any calculator used for laboratory dilution should be treated as a research tool only; neither the calculator nor the materials are for medical or clinical use.
The compliance context matters as much as the arithmetic. Research Sciences supplies research-use-only peptides, laboratory accessories and preparation tools for controlled in vitro research. The shop states that its products are not medicines, medical devices, injectables, treatments or food supplements under UK law, and that it does not provide therapeutic, medical, performance, injection, ingestion or dosing guidance. Its materials are labelled “For Research Use Only – Not for Human Consumption” as the shop’s stated position, not as legal advice. A transfer pack should repeat that all materials are not for human or veterinary use. Once a concentration plan is formatted as a dosing instruction, the laboratory record has been corrupted, even if no material has yet been prepared.
Documenting Stock, Diluent and Assay Concentration Without Creating a Dosing Template
A robust handover separates four records. First, material identity: product name, catalogue reference, vial label reference, expiry and the batch CoA. Second, stock preparation: the lyophilised or supplied form, diluent identity, diluent volume, temperature and mixing conditions, all clearly marked for laboratory use only. Third, dilution scheme: aliquot volume, intermediate container, vehicle and the sequence used to reach the assay concentration. Fourth, assay context: final in vitro concentration, matrix, plate or vessel, analytical method and time point. These are laboratory records, not dosing instructions, and the document should say so at the top of every page.
Unit discipline prevents most disputes. If a plan gives molarity, record how the conversion was made and cite the molecular weight from the batch CoA rather than borrowing a value from another product. If it gives mass concentration, state the exact form and whether the value refers to the stock vial or the diluted assay well. Avoid vague phrases such as “standard concentration” unless a controlled document defines them. A useful field structure is: stock concentration, diluent, aliquot removed, final assay volume, final in vitro concentration, and disposal route. Materials managers should also preserve the label reference and CoA reference in the same folder as the method, because identity and concentration records can become disconnected after a freezer move or a staff change.
Where fresh research material is needed, the receiving lab should review the current catalogue only after confirming the intended in vitro application and the batch CoA. Catalogue items remain research-use-only. Buy peptides from Research Sciences’ UK research catalogue only after suitability, storage and documentation have been checked, and read the product page with the batch CoA rather than assuming earlier wording still applies.
Reconstitution language needs particular care. In a laboratory workflow, a concentration plan may state diluent volume and the concentration prepared for an in vitro assay, but it must not become a template for administration. If the shop’s free reconstitution calculator is used, record the inputs and confirm that it is for laboratory research only; neither the calculator nor the materials are for medical or clinical use. The plan should never contain a human or veterinary dose, injection volume for a person or animal, or an administration schedule. Those categories sit outside the research-use-only remit and should be removed from any transferred document before work begins.
Handover Controls That Keep Concentration Plans as Laboratory Records
A controlled handover needs a named sender, a named receiver and a version-checked transfer pack. The pack should include the original method, raw preparation notes, batch CoAs, storage conditions, safety information and a unit audit signed by both sides. The receiving lab should confirm that every concentration statement is labelled as stock, intermediate or final in vitro assay concentration. If a line cannot be classified, the transfer should pause until it is corrected. This is not bureaucracy; it is how a laboratory prevents an informal note from becoming an unverified instruction.
A common scenario illustrates the risk. One lab transfers a plate-based in vitro assay to another and sends a concentration line that omits the diluent and the intermediate dilution step. The receiving lab interprets the figure as the final well concentration, prepares a different stock and records the result under the same method title. The arithmetic may be valid, but the experiment is not comparable. A better pack would state the material, batch CoA, diluent, stock concentration, aliquot volume, final assay volume and final in vitro concentration, with a note that the document is for laboratory research only. The receiving lab can then reproduce the workflow without inventing context. All materials remain not for human or veterinary use.
Materials managers should also separate identity controls from concentration controls. Vial cap colour and packaging may vary and, as Research Sciences’ FAQs explain, cap colour is not an indicator of identity, analytical quality or manufacturing origin. The vial label reference should be recorded and used when querying documentation. Research Sciences describes CoAs for every product and batch-level analytical documentation for supported products; the homepage lists “CoAs Janoshik Analytical Reports”. Those statements should be reconfirmed on the live site and, most importantly, against the CoA that accompanies the specific batch. The receiving lab should not infer purity, identity or suitability from a previous order or from a concentration plan alone.
Storage and handling notes belong in the same handover, but they should remain inside the in vitro workflow. Research Sciences’ handling guidance describes allowing vials to reach room temperature before opening, working in a clean environment, storing lyophilised peptides at –20°C or below with desiccant and protection from moisture, heat and light, and avoiding repeated freeze–thaw cycles. Reconstituted material is described as less stable and for short-term laboratory storage at 2–8°C. These are laboratory handling points, not clinical instructions. If a transferred concentration plan cannot be read alongside those controls, it is not ready for use.
Denver aerospace engineer trekking in Kathmandu as a freelance science writer. Cass deciphers Mars-rover code, Himalayan spiritual art, and DIY hydroponics for tiny apartments. She brews kombucha at altitude to test flavor physics.